STP-778

N/A

Report date: 2024/12/19 16:58:36
NME

Base Information

Drug NameSTP-778
Drug Alias NameSTP-778
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTransforming growth factor beta 1 inhibitorsProgrammed death-ligand 1 blockers
TargetsTransforming growth factor beta 1Programmed death-ligand 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSirnaomics Biopharmaceuticals (Suzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A